Similar to the results of MM cases, SOX7 transcript levels were significantly lower in high-risk SMM cases compared with control samples regardless of whether RPL37A (Figure 8C) or EMC7 (Figure 8D) was used for normalization of the SOX7 gene expression across the samples. The gene discussed is SOX7; the disease is Miyoshi myopathy.